Physician profile
Ying Luo
NPI 1235688094
$419.49
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $82.65 · 2023: $35.62 · 2024: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $66.78 | 2024 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $62.65 | 2022 | |
| Amgen INC. | $52.50 | 2024 | Krystexxa, Evenity |
| Lilly USA, LLC | $33.35 | 2024 | Jardiance, Mounjaro |
| Pfizer INC. | $23.75 | 2024 | |
| Abbvie INC. | $23.44 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $23.44 | 2024 | Rexulti |
| Amarin Pharma, INC. | $20.00 | 2022 | |
| Ardelyx, INC. | $19.26 | 2023 | Ibsrela |
| Janssen Pharmaceuticals, INC | $18.12 | 2024 | Xarelto |
| Esperion Therapeutics, INC. | $16.36 | 2023 | Nexletol |
| Merck Sharp & Dohme LLC | $15.63 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $15.62 | 2024 | Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.38 | 2024 | Trulance, Xifaxan |
| Novo Nordisk INC | $13.21 | 2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.